| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |